Horitzonts Tecnologics Hungary Korlátolt Felelosségu Társaság

Valoralia | Mas D, Sl

Neuron Biopharma, S.a.

Valoralia I Más D, S.l.u.

Valoralia I Más D, Sl

Ángel Rumbero Sánchez

Alfredo Hernández Cabanillas

Santiago Maderuelo Corral

Montserrat Ortega Doménech

Diego Fernando Rosero Valencia

Victor Tena Pérez

Javier Santos Burgos Muñoz

Javier Velasco Alvarez

José Luis Adrio Fondevila

Luis Néstor Apaza Ticona

Ana María González Fuente

Víctor Tena PÉREZ

Ana María GONZÁLEZ Fuente

Carlos Ramírez Moreno

Saleta Sierra ÁVila

Maria Del Carmen Ramos MARTÍN

Juan María Alfaro Sánchez

Sonia Campoy García

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer or solvate thereof for use in the prevention and/or treatment of a pathology associated with proinflammatory conditions, a disease associated with oxidative stress or production of reactive oxygen species or a skin pigmentation disorder. In addition, the invention also relates to a cosmetic method for preventing and/or treating skin aging, irradiated skin or for skin-whitening comprising administering a compound of formula (I) or a cosmetically acceptable salt, stereoisomer or solvate thereof. In addition, the invention relates to a method of inhibition of enzymatic browning in food or beverage comprising contacting said food or beverage with a compound of formula (I) or a salt, stereoisomer or solvate thereof under conditions sufficient to inhibit enzymatic browning of said food or beverage.

Uses of doxadiazines compounds

The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.

Compounds for treating infections

The invention relates to the use of 1-(4,6-dipentyl-5,6-dihydro-2H-1,2,3-oxadiazin-2-yl)-3-hydroxypropan-1-one in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compound of formula (I) of the invention, said process comprising the steps of cultivating a strain ofsp in an aqueous nutrient medium with assimilable carbon and nitrogen sources and salts, under controlled aerobic conditions, and then recovering the compound of general formula (I) from the culture broth.

Dihydrooxadiazine compounds for treating infections and cancer

The invention relates to novel compounds and their use in medicine, particularly in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compounds of the invention.

Compounds having antiinfective, antitumoral and antifungal activity

Growing community of inventors

Madrid, Spain

Ángel Rumbero Sánchez